Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | AURKA | O14965 | 2/20 | 0.35 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.35 |
| ▸ | MAPKAPK2 | P49137 | 4/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601377 | 0.96 | TSHR (0.39) | TSHRAURKAAURKBMAPKAPK2USP2 | |
| SCHEMBL17269396 | 0.95 | TSHR (0.39) | TSHRAURKAAURKBMAPKAPK2USP2 | |
| SCHEMBL19601370 | 0.92 | TSHR (0.36) | TSHRAURKAAURKBMAPKAPK2USP2 | |
| SCHEMBL23152945 | 0.91 | TSHR (0.48) | TSHRMAPKAPK2ALDH1A1 | |
| SCHEMBL19601153 | 0.91 | TSHR (0.35) | TSHRAURKAAURKBMAPKAPK2USP2 | |
| SCHEMBL17269435 | 0.90 | TSHR (0.37) | TSHRAURKAAURKBMAPKAPK2 | |
| SCHEMBL18905098 | 0.90 | TSHR (0.45) | TSHRMAPKAPK2ALDH1A1 | |
| SCHEMBL17269408 | 0.90 | AURKA (0.42) | TSHRAURKAAURKB | |
| SCHEMBL19601247 | 0.85 | MAPKAPK2 (0.35) | TSHRMAPKAPK2USP2ALDH1A1HSD17B10 | |
| SCHEMBL2704646 | 0.85 | ALDH1A1 (0.45) | TSHRMAPKAPK2USP2ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | DIC CORPORATION (JP) | 2021-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | EPB41, F12, CDK1 | TSHR 4803/4885AURKA 2025/4885AURKB 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.